- Product Tours
*Using the buttons below, Eureka Clinical AI partners can be filtered by whether or not they have an FDA Cleared algorithm on the Eureka AI Exchange.
Develops solutions to extract a rich set of biomarkers from MRI T1 and FLAIR images supporting radiologists and neurologists in detection, differential diagnosis, and management of neurodegenerative diseases.
Using visionary thinking and service leadership to drive the quality of patient care by enabling deeper insight to physicians and researchers at hospitals, universities and imaging centers worldwide.
Developing an advanced imaging analytics platform powered by machine learning algorithms that deliver actionable insights at point-of-care for high-quality personalized breast health.
An FDA-cleared brain MRI tool that is intended for automatic labeling, visualization, and volumetric quantification of segmentable brain structures from a set of MR images.
Develops and provides quantitative analytical solutions that enable clinicians to better visualize, diagnose, and treat diseases with greater confidence.
Develops artificial intelligence software to interpret medical images that enable physicians to make faster, more accurate decisions when diagnosing stroke, brain trauma, and other serious conditions.
Transforming standard medical images into rich visual maps of patient conditions and quantitative reports that provide physicians detailed data to enable more personalized care decisions.
Specializes in the development and delivery of non-invasive medical imaging software and services.
Riverain Technologies is dedicated to thoracic imaging, providing software tools to aid clinicians in the efficient, effective early detection of lung disease.
VIDA is transforming pulmonary care through intelligence. LungPrint aims to provide greater precision and efficiency in the reporting of chest CTs.
Providing artificial intelligence tools to enhance radiologist performance.
Augmenting Physicians' Diagnostic ability with an artificially intelligent medical image analysis system.
Develops deep learning-based technology enabling 3D image search for large medical image data and connected clinical information.
Creating next generation diagnostic software by realising the big-data analytics potential in medical imaging and automating time consuming and expert-dependent analyses.
CorticoMetrics seeks to improve the state of clinical decision making in neuroradiology.
Offering computer-vision and artificial intelligence solutions for the prediction and assessment of bone diseases like osteoarthritis, which affects over 30 million US adults.
Leveraging artificial intelligence and deep learning to develop medical image analysis technology that radiologists and patients can confidently rely on.
InferRead™ CT Lung is in use at over 300 facilities. InferRead CT Lung detects and classifies lung nodules quickly and accurately. All data is auto-routed to PACS, EMR, and reporting systems.
Applying advanced algorithms to medical images to objectively measure disease or treatment-derived alterations in organs and tissues, offering additional quantitative information to the naked eye of radiologists.
Lunit is a venture company devoted to developing advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology.
Develops cutting-edge deep learning technology that helps detect and highlight abnormalities in medical images.
Innovates clinical workﬂow by solving medical problems using data-driven machine learning technology.